Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-line therapy of advanced-stage follicular lymphoma in medically non-fit patients
2016-000755-27Phase 2Completed
- Sponsor
- LMU Klinikum
- Start
- Jul 2016
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in follicular lymphoma (FL) comparing Gazyvaro monotherapy with Gazyvaro + Levact followed by Gazyvaro (2 arms). Primary endpoint: Overall response rate. Started Jul 2016; status: completed.
02
Drugs
obinutuzumabbendamustine
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on 2016-000755-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000755-27.